Angiotensin (1-7) vs Foxo4-DRI

Both are Longevity peptides.

Angiotensin (1-7)

Ang-(1-7)

LongevityLow Risk

No providers listed yet

Full Angiotensin (1-7) profile →

Foxo4-DRI

Foxo4-D-Retro-Inverso

LongevityMedium Risk

Half-life: Unknown

12 providers listed

Full Foxo4-DRI profile →

Quick Verdict

Angiotensin (1-7)

Risk

Low

Foxo4-DRI

Risk

Medium

Side-by-Side Comparison

Angiotensin (1-7)

Foxo4-DRI

About Angiotensin (1-7)

Binds Mas receptor (MasR), activating nitric oxide synthase and reducing oxidative stress. Opposes TGF-β and angiotensin II signaling to reduce fibrosis. Enhances insulin sensitivity and provides cardiovascular protection.

A heptapeptide formed from angiotensin II via ACE2 cleavage, or from angiotensin I via neprilysin. Acts as the endogenous counter-regulatory axis to angiotensin II — producing vasodilation, anti-fibrotic, and metabolic benefits via the Mas receptor.

Research Areas

cardiovascular protectionanti-fibroticvasodilationinsulin sensitivitykidney protection

About Foxo4-DRI

D-retro-inverso peptide that disrupts Foxo4/p53 interaction in senescent cells; restores p53-mediated apoptosis selectively in senescent cells; clears cellular "zombie cells"

A breakthrough senolytic peptide that selectively eliminates senescent cells by restoring their ability to undergo apoptosis. Produced dramatic rejuvenation effects in preclinical studies.

Research Areas

senescent cell clearancetissue rejuvenationhealthspan extensionsenolytic

Find Providers

Where to source these peptides

Providers offering

Angiotensin (1-7)

Browse directory →

Providers offering

Foxo4-DRI

12 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More longevity Comparisons

Browse all peptides →

Educational research tools — not medical advice.